Your browser doesn't support javascript.
loading
Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov, Ido; Abou-Nader, Paul; Amin, Oreekha; Philip, Charles-Andre; Beauchamp, Marie-Claude; Yasmeen, Amber; Gotlieb, Walter H.
Affiliation
  • Laskov I; *Division of Gynecologic Oncology, Jewish General Hospital; †Segal Cancer Center, Lady Davis Institute of Medical Research; and ‡Department of Oncology, McGill University, Montreal, Quebec, Canada.
Int J Gynecol Cancer ; 26(7): 1213-21, 2016 09.
Article in En | MEDLINE | ID: mdl-27643646

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Endometrial Neoplasms / Epithelial-Mesenchymal Transition / Hypoglycemic Agents / Metformin Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2016 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Endometrial Neoplasms / Epithelial-Mesenchymal Transition / Hypoglycemic Agents / Metformin Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2016 Type: Article Affiliation country: Canada